Stuart B. Levy

1.7k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Stuart B. Levy is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Stuart B. Levy has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Stuart B. Levy's work include Antibiotic Resistance in Bacteria (6 papers), Tuberculosis Research and Epidemiology (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Stuart B. Levy is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Tuberculosis Research and Epidemiology (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Stuart B. Levy collaborates with scholars based in United States, Nepal and United Kingdom. Stuart B. Levy's co-authors include Laura M. McMurry, Margret Oethinger, Judd L. Walson, Bharat Mani Pokhrel, Bonnie Marshall, Changcheng Yin, Adrian R. Walmsley, Per A. Bullough, M. Inês Borges‐Walmsley and Robert W. Taylor and has published in prestigious journals such as JAMA, The Journal of Infectious Diseases and Molecular Microbiology.

In The Last Decade

Stuart B. Levy

10 papers receiving 1.1k citations

Hit Papers

The Challenge of Antibiotic Resistance 1998 2026 2007 2016 1998 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart B. Levy United States 9 353 352 324 227 167 10 1.2k
Wanda Reygaert United States 8 436 1.2× 470 1.3× 187 0.6× 129 0.6× 199 1.2× 15 1.9k
Alfonso J. Alanis United States 5 196 0.6× 345 1.0× 108 0.3× 134 0.6× 118 0.7× 7 1.1k
Richard J. Fair Germany 9 416 1.2× 649 1.8× 166 0.5× 378 1.7× 170 1.0× 11 1.9k
Parjit Kaur United States 11 320 0.9× 484 1.4× 222 0.7× 77 0.3× 69 0.4× 16 1.1k
Muhammad Khalid Farooq Salamat United Kingdom 9 434 1.2× 739 2.1× 218 0.7× 198 0.9× 264 1.6× 16 2.0k
Porooshat Dadgostar United States 5 364 1.0× 282 0.8× 177 0.5× 108 0.5× 346 2.1× 7 1.3k
Matthew P. McCusker Ireland 17 623 1.8× 524 1.5× 189 0.6× 134 0.6× 58 0.3× 22 1.7k
Sirijan Santajit Thailand 9 570 1.6× 535 1.5× 152 0.5× 131 0.6× 142 0.9× 19 1.4k
Ilyas Alav United Kingdom 10 619 1.8× 576 1.6× 213 0.7× 150 0.7× 75 0.4× 15 1.5k
Muhammad Aamir Aslam Pakistan 9 472 1.3× 656 1.9× 228 0.7× 208 0.9× 266 1.6× 20 2.0k

Countries citing papers authored by Stuart B. Levy

Since Specialization
Citations

This map shows the geographic impact of Stuart B. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart B. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart B. Levy more than expected).

Fields of papers citing papers by Stuart B. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart B. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart B. Levy. The network helps show where Stuart B. Levy may publish in the future.

Co-authorship network of co-authors of Stuart B. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart B. Levy. A scholar is included among the top collaborators of Stuart B. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart B. Levy. Stuart B. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Levy, Stuart B.. (2007). Antibiotic Resistance: An Ecological Imbalance. Novartis Foundation symposium. 207. 1–14. 106 indexed citations
2.
Walson, Judd L., et al.. (2001). Carriage of Antibiotic‐Resistant Fecal Bacteria in Nepal Reflects Proximity to Kathmandu. The Journal of Infectious Diseases. 184(9). 1163–1169. 60 indexed citations
3.
Wong, Rebecca S.Y., Laura M. McMurry, & Stuart B. Levy. (2000). ‘Intergenic’blr gene in Escherichia coli encodes a 41‐residue membrane protein affecting intrinsic susceptibility to certain inhibitors of peptidoglycan synthesis. Molecular Microbiology. 37(2). 364–370. 18 indexed citations
4.
Yin, Changcheng, M. Inês Borges‐Walmsley, Robert W. Taylor, et al.. (2000). The quarternary molecular architecture of TetA, a secondary tetracycline transporter from Escherichia coli. Molecular Microbiology. 38(3). 482–492. 40 indexed citations
5.
Levy, Stuart B.. (1998). The Challenge of Antibiotic Resistance. Scientific American. 278(3). 46–53. 600 indexed citations breakdown →
6.
McMurry, Laura M., Margret Oethinger, & Stuart B. Levy. (1998). Overexpression ofmarA, soxS, oracrABproduces resistance to triclosan in laboratory and clinical strains ofEscherichia coli. FEMS Microbiology Letters. 166(2). 305–309. 280 indexed citations
7.
Levy, Stuart B., et al.. (1998). Reversing Tetracycline Resistance. Advances in experimental medicine and biology. 456. 17–25. 6 indexed citations
8.
Levy, Stuart B.. (1995). Antimicrobial Resistance: A Global Perspective. PubMed. 390. 1–13. 12 indexed citations
9.
Levy, Stuart B.. (1993). Confronting Multidrug Resistance. JAMA. 269(14). 1840–1840. 38 indexed citations
10.
Levy, Stuart B., et al.. (1989). Chromatin reorganization during emergence of malignant Friend tumors: Early changes in H2A and H2B variants and nucleosome repeat length. Experimental Cell Research. 180(1). 209–219. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026